FlandersBio on Twitter

Galapagos NV: business update: http://t.co/6w1jppWE

Follow us on Twitter

Flanders vaccine

in english

Flanders vaccine aims to stimulate innovation in vaccine related research & business as well as to catalyse public-private partnerships. Flanders vaccine brings together large companies, SMEs with vaccine activities (active in vaccine development & delivery and biostatistics), CROs, universities, university hospitals and research institutes.

Flanders vaccine

Aims & Mission Statement

Flanders vaccine aims to create an overview of knowledge/expertise and equipment on vaccine related research & services, to give an overview of who is who in the field and to identify R&D themes in the field by

Why joining?

To become a Flanders vaccine member, you should join FlandersBio first. More information about FlandersBio membership.

More info about this project?

If you wish to post information on this page, or if you have any further questions, you can send us an email.

Founding partners

Flanders vaccine

Project Members

Apitope International BioMARIC EUROGENTEC MUbio Pfizer Biotech Incubation Partners MSD Oxyrane Belgium SGS Life Science Services, a division of SGS Belgium University of Antwerp Antwerp University Hospital Hasselt University UGent Janssen Pharmaceutica FluidDa Institute of Tropical Medicine Antwerp (ITM) VITO Vrije Universiteit Brussel Applied Maths Complix Harrison Clinical Research Benelux Janssen Infectious Diseases - Diagnostics Janssen Diagnostics Okapi Sciences IWT KU Leuven VIB CHHC FlandersBio Vaxinfectio Provaxs

Back to top

Print